Ariagen, Inc.
Records under this name other than the patents Ariagen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 4 of 4 · Back to Ariagen, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,547,698 | Aryl hydrocarbon receptor modulators Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,081,610 | Efficient and Scalable Synthesis of 2-(1'H-INDOLE-3'-Carbonyl)-THIAZOLE-4-Carboxylic Acid Methyl Ester and Its Structural Analogs Lapsed on the fee record Ended Sep 25, 2026 · High confidence | Lapsed on the fee record | Ended Sep 25, 2026 | High confidence |
| US 8,604,067 | ITE for cancer intervention and eradication Lapsed on the fee record Ended Dec 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2025 | From the USPTO record |
| US 9,694,000 | ITE for cancer intervention and eradication Lapsed on the fee record Ended Jul 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 4, 2025 | From the USPTO record |